Bridgeway Capital Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.6K | Hold |
88,500
| – | – | ﹤0.01% | 1108 |
|
|
2025
Q1 | $68K | Sell |
88,500
-22,500
| -20% | -$17.3K | ﹤0.01% | 1097 |
|
|
2024
Q4 | $142K | Sell |
111,000
-65,100
| -37% | -$83K | ﹤0.01% | 1060 |
|
|
2024
Q3 | $365K | Buy |
176,100
+52,500
| +42% | +$109K | 0.01% | 932 |
|
|
2024
Q2 | $471K | Hold |
123,600
| – | – | 0.01% | 871 |
|
|
2024
Q1 | $586K | Sell |
123,600
-25,149
| -17% | -$119K | 0.01% | 880 |
|
|
2023
Q4 | $635K | Buy |
148,749
+111,800
| +303% | +$477K | 0.01% | 881 |
|
|
2023
Q3 | $114K | Hold |
36,949
| – | – | ﹤0.01% | 1200 |
|
|
2023
Q2 | $166K | Hold |
36,949
| – | – | ﹤0.01% | 1176 |
|
|
2023
Q1 | $211K | Hold |
36,949
| – | – | 0.01% | 1097 |
|
|
2022
Q4 | $223K | Hold |
36,949
| – | – | 0.01% | 1065 |
|
|
2022
Q3 | $244K | Sell |
36,949
-10,000
| -21% | -$66K | 0.01% | 1094 |
|
|
2022
Q2 | $245K | Buy |
+46,949
| New | +$245K | 0.01% | 1048 |
|